Skip to content

Clinical trials

Phase 2 Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 2 Clear all

199 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20015
20021
20033
20046
200511
200610
200716
20087
200915
201013
20114
20127
20135
20148
20153
20164
20175
20184
20193
20203
20215
20224
20236
20243
20254
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed149
Unknown status19
Withdrawn10
Recruiting9
Terminated6
Not yet recruiting5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)24
Medical University of South Carolina13
Yale University10
University of Chicago7
Johns Hopkins University6
New York State Psychiatric Institute6
VA Office of Research and Development5
The University of Tennessee, Knoxville4
Boston Medical Center3
Centre hospitalier de l'Université de Montréal (CHUM)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders199
Opioid-Related Disorders36
Cocaine-Related Disorders30
Alcoholism28
Stress Disorders, Post-Traumatic10
Mental Disorders9
Alcohol-Related Disorders8
HIV Infections8
Heroin Dependence7
Anxiety Disorders6

Trials

Showing 51 to 75 of 199. Each trial links to its page on Pharma Observatory.

99 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.